TNSN01080A1 - Derives d'hygromycine nouveaux et compositions les contenant . - Google Patents

Derives d'hygromycine nouveaux et compositions les contenant .

Info

Publication number
TNSN01080A1
TNSN01080A1 TNTNSN01080A TNSN01080A TNSN01080A1 TN SN01080 A1 TNSN01080 A1 TN SN01080A1 TN TNSN01080 A TNTNSN01080 A TN TNSN01080A TN SN01080 A TNSN01080 A TN SN01080A TN SN01080 A1 TNSN01080 A1 TN SN01080A1
Authority
TN
Tunisia
Prior art keywords
compositions containing
compounds
novel
infections
derivatives
Prior art date
Application number
TNTNSN01080A
Other languages
English (en)
Inventor
Merrill Hayward Matthew
Gerald Linde Ii Robert
Kaneko Takushi
Scott Visser Michael
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of TNSN01080A1 publication Critical patent/TNSN01080A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/203—Monocyclic carbocyclic rings other than cyclohexane rings; Bicyclic carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

L'INVENTION CONCERNE DES COMPOSES DE FORMULE 1 : DANS LAQUELLE R1, R2, R3 ET R10 REPRESENTENT DIVERS RADICAUX. ELLE CONCERNE EGALEMENT DES COMPOSITIONS CONTENANT CES COMPOSES. APPLICATION : UTILISATION DE CES COMPOSES ET COMPOSITIONS POUR LE TRAITEMENT DE DIVERSES INFECTIONS BACTERIENNES ET INFECTIONS PAR DES PROTOZOAIRES, AINSI QUE D'AFFECTIONS EN RAPPORT AVEC DE TELLES INFECTIONS.
TNTNSN01080A 2000-06-02 2001-06-01 Derives d'hygromycine nouveaux et compositions les contenant . TNSN01080A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20902300P 2000-06-02 2000-06-02

Publications (1)

Publication Number Publication Date
TNSN01080A1 true TNSN01080A1 (fr) 2005-11-10

Family

ID=22777009

Family Applications (1)

Application Number Title Priority Date Filing Date
TNTNSN01080A TNSN01080A1 (fr) 2000-06-02 2001-06-01 Derives d'hygromycine nouveaux et compositions les contenant .

Country Status (31)

Country Link
US (1) US6867230B2 (fr)
EP (1) EP1287011A1 (fr)
JP (1) JP2003535100A (fr)
KR (1) KR20030010655A (fr)
CN (1) CN1432019A (fr)
AP (1) AP2002002669A0 (fr)
AR (1) AR028667A1 (fr)
AU (1) AU2001260528A1 (fr)
BG (1) BG107265A (fr)
BR (1) BR0111242A (fr)
CA (1) CA2410643A1 (fr)
CZ (1) CZ20023859A3 (fr)
EA (1) EA200201167A1 (fr)
EC (1) ECSP014093A (fr)
EE (1) EE200200671A (fr)
GT (1) GT200100099A (fr)
HU (1) HUP0302263A2 (fr)
IL (1) IL152984A0 (fr)
IS (1) IS6618A (fr)
MA (1) MA26909A1 (fr)
MX (1) MXPA02011966A (fr)
NO (1) NO20025704D0 (fr)
OA (1) OA12277A (fr)
PA (1) PA8518101A1 (fr)
PE (1) PE20020334A1 (fr)
PL (1) PL359179A1 (fr)
SK (1) SK16612002A3 (fr)
SV (1) SV2002000474A (fr)
TN (1) TNSN01080A1 (fr)
UY (1) UY26741A1 (fr)
WO (1) WO2001092280A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101087883B1 (ko) 2002-05-16 2011-11-30 선오비온 파마슈티컬스 인코포레이티드 포유류 아난다미드 운반물질을 억제하는 아민, 및 이의사용 방법
US20210275559A1 (en) * 2018-08-20 2021-09-09 Kim Lewis Hygromycin a compounds and methods of treating spirochete diseases
CU20180159A7 (es) * 2018-12-28 2020-10-20 Chengdu Olisynn Biotechnology Co Ltd Derivados de oligosacáridos sintéticos como vacuna contra la bordetella pertussis

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1234567A (en) * 1915-09-14 1917-07-24 Edward J Quigley Soft collar.
US2004123A (en) * 1934-02-15 1935-06-11 Jr Robert B Loibl Pest exterminator
MA24852A1 (fr) * 1998-05-04 1999-12-31 Pfizer Prod Inc Derives d'hygromycine a et leur procede de preparation
CA2331261C (fr) * 1998-05-04 2004-07-27 Pfizer Products Inc. Derives 2"-desoxy-hygromycine
PL348063A1 (en) * 1998-12-02 2002-05-06 Pfizer Prod Inc Hygromycin a derivatives as antibacterial agents
EP1224197A1 (fr) * 1999-10-29 2002-07-24 Pfizer Products Inc. Derives d'hygromycine
US7654321B2 (en) * 2006-12-27 2010-02-02 Schlumberger Technology Corporation Formation fluid sampling apparatus and methods

Also Published As

Publication number Publication date
UY26741A1 (es) 2001-12-28
CN1432019A (zh) 2003-07-23
EP1287011A1 (fr) 2003-03-05
WO2001092280A1 (fr) 2001-12-06
CA2410643A1 (fr) 2001-12-06
BR0111242A (pt) 2003-06-03
ECSP014093A (es) 2002-01-25
AR028667A1 (es) 2003-05-21
EE200200671A (et) 2004-08-16
PL359179A1 (en) 2004-08-23
SK16612002A3 (sk) 2004-04-06
US20030045528A1 (en) 2003-03-06
SV2002000474A (es) 2002-07-03
EA200201167A1 (ru) 2003-06-26
NO20025704L (no) 2002-11-27
OA12277A (en) 2006-05-11
BG107265A (bg) 2003-07-31
AU2001260528A1 (en) 2001-12-11
IS6618A (is) 2002-11-14
AP2002002669A0 (en) 2002-12-31
JP2003535100A (ja) 2003-11-25
MA26909A1 (fr) 2004-12-20
PA8518101A1 (es) 2002-09-17
NO20025704D0 (no) 2002-11-27
IL152984A0 (en) 2003-06-24
CZ20023859A3 (cs) 2004-02-18
GT200100099A (es) 2002-01-31
KR20030010655A (ko) 2003-02-05
MXPA02011966A (es) 2003-04-22
HUP0302263A2 (hu) 2003-10-28
PE20020334A1 (es) 2002-04-30
US6867230B2 (en) 2005-03-15

Similar Documents

Publication Publication Date Title
TNSN98238A1 (fr) Macrolides nouveaux
TNSN98082A1 (fr) DERIVES SUBSTITUES EN C - 4 DE 9 - DESOXO - 9a - aza - 9a HOMOERYTHROMYCINE A.
TNSN01048A1 (fr) Acides malonamiques et leurs derives, et compositions les contenant
TNSN01132A1 (fr) Derives de pyrazole nouveaux et compositions les contenant.
TNSN01095A1 (fr) DERIVES DE PYRROLO [2,3-d] PYRIMIDINE NOUVEAUX ET COMPOSITIONS LES CONTENANT
TNSN98084A1 (fr) Derives de macrolides substitues en position c-4
TNSN00228A1 (fr) Derives de benzimidazole nouveaux, et compositions les contenant
TNSN01114A1 (fr) Derives d'imidazole nouveaux et compositions les contenant
TNSN99170A1 (fr) Derives de tetrahydroquinoleine substitues nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN02011A1 (fr) Derives de pyrimidine bicycliques nouveaux, inhibiteurs de mmp, et compositions les contenant
TNSN02032A1 (fr) Derives de glutaramide a substituant n-phenpropylcyclopentyle nouveaux, et compositions les contenant.
TNSN02014A1 (fr) Composes nouveaux agonistes de ppar et compositions les contenant
TNSN01091A1 (fr) Derives bicycliques nouveaux, compositions les contenant et leur utilisation pour le traitement d'une croissance cellulaire anormale
TNSN01102A1 (fr) Derives de pyrazole nouveaux, procede pour leur preparation et compositions les contenant.
TNSN99106A1 (fr) Derives d'isothiazole nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA29160B1 (fr) Derives de triazole substitues, servant d'antagonistes d'ocytocine
TNSN02037A1 (fr) Sulfonylpyridazinones nouvelles inhibitrices d'aldose reductase et compositions les contenant
TNSN99006A1 (fr) 4-(2-ceto-1-benzimidazolinyl) piperidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98194A1 (fr) Derives nouveaux de 6-o-methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99236A1 (fr) Derives bicycliques substitues nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant.
TNSN99172A1 (fr) 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN99252A1 (fr) Composes nouveaux modulateurs de chimiokine ccr5 et compositions pharmaceutiques les contenant.
TNSN98203A1 (fr) Derives de thienopyrimidine et tienopyridine utiles comme agents anticancereux, et compositions les contenant
TNSN02008A1 (fr) Derives d'acides isophtalique nouveaux inhibiteurs de mmp, et compositions les contenant
TNSN97110A1 (fr) Derives de 2-(2-oxo-ethylidene)-imidazolidine-4-one, procede pour leur preparation et compositions pharmaceutiques les contenant